Driehaus Capital Management’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $462K | Hold |
1,400,191
| – | – | ﹤0.01% | 389 |
|
|
2025
Q1 | $437K | Hold |
1,400,191
| – | – | ﹤0.01% | 369 |
|
|
2024
Q4 | $1.31M | Hold |
1,400,191
| – | – | 0.01% | 322 |
|
|
2024
Q3 | $1.65M | Hold |
1,400,191
| – | – | 0.01% | 303 |
|
|
2024
Q2 | $1.08M | Buy |
+1,400,191
| New | +$1.08M | 0.01% | 304 |
|
|
2023
Q2 | – | Sell |
-1,257,337
| Closed | -$3.24M | – | 449 |
|
|
2023
Q1 | $3.24M | Sell |
1,257,337
-172,931
| -12% | -$446K | 0.05% | 311 |
|
|
2022
Q4 | $2.66M | Hold |
1,430,268
| – | – | 0.04% | 286 |
|
|
2022
Q3 | $2.63M | Buy |
1,430,268
+86,943
| +6% | +$160K | 0.04% | 298 |
|
|
2022
Q2 | $2.89M | Buy |
1,343,325
+983,349
| +273% | +$2.11M | 0.05% | 291 |
|
|
2022
Q1 | $1.13M | Buy |
+359,976
| New | +$1.13M | 0.01% | 325 |
|
|
2018
Q4 | – | Sell |
-211,107
| Closed | -$1.2M | – | 487 |
|
|
2018
Q3 | $1.2M | Sell |
211,107
-74,192
| -26% | -$421K | 0.04% | 333 |
|
|
2018
Q2 | $2.23M | Buy |
285,299
+1,381
| +0.5% | +$10.8K | 0.08% | 258 |
|
|
2018
Q1 | $2.01M | Buy |
283,918
+12,221
| +4% | +$86.4K | 0.07% | 265 |
|
|
2017
Q4 | $2.68M | Buy |
271,697
+6,800
| +3% | +$67.1K | 0.1% | 233 |
|
|
2017
Q3 | $2.27M | Buy |
264,897
+47,056
| +22% | +$403K | 0.09% | 239 |
|
|
2017
Q2 | $2.29M | Buy |
+217,841
| New | +$2.29M | 0.08% | 239 |
|